Rule 97 of Drug & Cosmetics Act 1945, provides for printing caution/ Warning in respect of drugs covered under Schedule H, Schedule G and substance covered under the purview of Narcotic & Psychotropic drugs Act, 1985 for the information of patients, doctors pharmacists and others so that there is no misuse of these drugs. It is observed that the caution does not appear in conspicuous manner on the innermost label of these drugs. This leads to unethical use of these medicines by the patients because of difficulty in reading/noticing the cautionary note provided on the label.
Hence all the manufacturers are requested to provide the caution / warning notice on the label in conspicuous manner to attract the attention.
A CDSCO inspection is one of the most consequential events in a Medical Device company’s regulatory journey in India. Whether you are a manufacturer or Importer, demonstrating compliance with th..
Introduction Stem cell therapy represents one of the most scientifically promising and regulatorily complex frontiers in modern medicine. India’s stem cell regulatory landscape presents both gen..
Three Regulatory Bodies, One Physical Label A Cosmetic label entering India is reviewed — directly or through market surveillance — against the requirements of three separate regulatory frameworks..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)